NCT06748001 2026-02-09Avapritinib Rollover StudyBlueprint Medicines CorporationPhase 4 Recruiting60 enrolled
NCT07270835 2025-12-08Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell LymphomaThe First Affiliated Hospital of Soochow UniversityPhase 4 Recruiting40 enrolled